Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer

Xue Huang; Mingming Fang; Lin Zhu; Cheng Gu; Han Cui; Chun Yang; Yuxing Yang

doi:10.12659/MSM.930457

07 September 2021 : Clinical Research

Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer

Xue Huang^1ABCDEFG, Mingming Fang^2BCF, Lin Zhu^1BCDF, Cheng Gu^2ABG, Han Cui^3BCDG, Chun Yang^4ACDF, Yuxing Yang^1ABDF*

DOI: 10.12659/MSM.930457

Med Sci Monit 2021; 27:e930457

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 (A, B) The disease-free survival (DFS) was longer in the extended-field group than in the pelvic-field group (χ2=4.79, P=0.0286). The 3-year survival rate was 86.15% in the extended-field group and 64.29% in the pelvic-field group. There was no significant difference in 3-year overall survival between the 2 groups (χ2=0.10, P=0.7460).

Back to the Article

Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer

Your Privacy